OSLO: Nordic Nanovector ASA has announced changes to its Executive Management Team. As a result of the cost-saving initiatives announced on 2 April 2020, the Board of Directors of Nordic Nanovector has restructured the senior management team.

The restructuring has resulted in the number of executives being reduced from nine to seven.

Malene Brondberg, Vice President Investor Relations and Corporation Communications, has been appointed CFO, effective 1 May, reporting to Lars Nieba, interim CEO. Malene Brondberg will in her new role as CFO be responsible for the areas Finance, Human Resources and Investor Relations.

Tone Kvåle and Rita Dege leave from their respective roles as Chief Financial Officer and Chief Human Resources Officer as of 1 May 2020.

Ms. Brondberg joined Nordic Nanovector in February 2018 bringing over 20 years’ operational experience in the financial services sector. Her career has included Global Head of Research managing a team of 67 people and member of the Executive Committee of the Nordic investment bank ABG Sundal Collier.

Since 2011, Ms. Brondberg has worked as a management consultant within the financial sector, acting as an advisor in relation to investor relations and funding, and has held various interim CEO, COO and Head of Compliance/HR/Finance management positions.

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.